Gurkishan Singh Chadha
Gurkishan Singh Chadha
University of New England, Maine
Verified email at
Cited by
Cited by
Physicochemical characterization of efavirenz–cyclodextrin inclusion complexes
S Sathigari, G Chadha, YHP Lee, N Wright, DL Parsons, VK Rangari, ...
Aaps Pharmscitech 10 (1), 81-87, 2009
Gefitinib-cyclodextrin inclusion complexes: physico-chemical characterization and dissolution studies
YH Phillip Lee, S Sathigari, YJ Jean Lin, WR Ravis, G Chadha, ...
Drug development and industrial pharmacy 35 (9), 1113-1120, 2009
In vitro percutaneous absorption of genistein from topical gels through human skin
G Chadha, S Sathigari, DL Parsons, R Jayachandra Babu
Drug development and industrial pharmacy 37 (5), 498-505, 2011
Effect of Type 2 Diabetes Mellitus and Diabetic Nephropathy on IgG Pharmacokinetics and Subcutaneous Bioavailability in the Rat.
GS Chadha, ME Morris
AAPS J 17 (4), 965-75, 2015
Transdermal iontophoretic delivery of selegiline hydrochloride, in vitro
CS Kolli, G Chadha, J Xiao, DL Parsons, RJ Babu
Journal of drug targeting 18 (9), 657-664, 2010
An Extended Minimal Physiologically Based Pharmacokinetic Model: Evaluation of Type II Diabetes Mellitus and Diabetic Nephropathy on Human IgG Pharmacokinetics in Rats
GS Chadha, ME Morris
The AAPS journal 17 (6), 1464-1474, 2015
Effect of chronic γ-hydroxybutyrate (GHB) administration on GHB toxicokinetics and GHB-induced respiratory depression
BL Morse, GS Chadha, MA Felmlee, KE Follman, ME Morris
The American Journal of Drug and Alcohol Abuse, 1-8, 2017
Monoclonal Antibody Pharmacokinetics in Type 2 Diabetes Mellitus and Diabetic Nephropathy
GS Chadha, ME Morris
Current Pharmacology Reports 2 (2), 45-56, 2016
Transdermal Delivery of Genistein as a Chemoprotective Drug for Melanoma
G Chadha
IgG pharmacokinetics in a rat model of type 2 diabetes mellitus and diabetic nephropathy
GS Chadha
State University of New York at Buffalo, 2015
The system can't perform the operation now. Try again later.
Articles 1–10